FLSW vs. NOVN.SW

In the year-to-date period, FLSW achieves a 1.43% return, which is significantly lower than NOVN.SW's 12.39% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The correlation between FLSW and NOVN.SW is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

This table presents a comparison of risk-adjusted performance metrics for Franklin FTSE Switzerland ETF (FLSW) and Novartis AG (NOVN.SW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FLSW Sharpe Ratio is 0.71, which is comparable to the NOVN.SW Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of FLSW and NOVN.SW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FLSW's dividend yield for the trailing twelve months is around 2.08%, less than NOVN.SW's 3.59% yield.

The maximum FLSW drawdown since its inception was -28.16%, smaller than the maximum NOVN.SW drawdown of -42.25%. Use the drawdown chart below to compare losses from any high point for FLSW and NOVN.SW. For additional features, visit the drawdowns tool.

The current volatility for Franklin FTSE Switzerland ETF (FLSW) is 3.76%, while Novartis AG (NOVN.SW) has a volatility of 5.85%. This indicates that FLSW experiences smaller price fluctuations and is considered to be less risky than NOVN.SW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.